The FDA warns that the osteoporosis drug Reclast (zoledronic acid) raises the risk of kidney failure.
View post:
FDA: Osteoporosis Drug Reclast Ups Kidney Failure Risk
You must be logged in to post a comment.
Posted by
on September 1, 2011. Filed under